Remote Monitored Systems appoints Dr. Gareth Cave and Dr. Felicity Sartain to its Board as Non-Executive Directors

– UK, London –  Remote Monitored Systems PLC (LON: RMS) today announced the appointments of Dr Gareth Cave and Dr Felicity Sartain to its Board as non-executive directors, effective immediately.

Dr. Felicity Sartain will be an independent non-executive director.

“We are delighted to welcome both Gareth and Felicity to the Board. They are both highly accomplished in their fields with deep knowledge and experience in nanotechnology. The appointments strengthen and extend the Board’s skill set, and we very much look forward to benefitting over the coming years as their contributions support RMS’s growth trajectory.” said Executive Chairman, Antony Legge.

About Dr. Gareth Cave

Dr. Gareth Cave is a founder and Chairman of Pharm2Farm Ltd, the Company’s wholly-owned subsidiary. Dr. Cave gained his BSc, MSc, and Ph.D. in Chemistry from the University of Warwick. He subsequently co-established the Australian Centre for Green Chemistry at Monash University in Australia, whilst also pioneering a new “green” solvent-free chemical reaction process, that later led to the two patents licenced to P2F to manufacture and fictionalise their nanotechnology processes. Dr Cave later went on to work as an academic at the Universities of Leeds, Liverpool and University of Missouri, USA before returning to the UK at Nottingham Trent University in 2005 where he is currently Head of Inorganic Chemistry. His current interdisciplinary university research group, of 11 Ph.D.’s utilize nanotechnology across a plethora of applications from cancer immunology, and treatments of Alzheimer’s through to food security – both plant and livestock.

About Dr. Felicity Sartain

Dr Felicity Sartain has a multi-disciplinary background established over 10 years including managerial, commercial, and research in the Healthcare, Life Science, and Nanotechnology sectors. She holds a Ph.D. in Biotechnology from the University of Cambridge and an MSc in Chemistry at the University of York. She has also undertaken Post-Doctoral Research at the University of Cambridge following an industrial placement with GlaxoSmithKline. Felicity is currently Chief Operating Officer of Closed Loop Medicine where she initially worked as a consultant from September 2017.

For more information: https://www.remotemonitoredsystems.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.